[What we want to know about multiple sclerosis]. 1975

I Feghelm

UI MeSH Term Description Entries
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

I Feghelm
April 1987, Soins; la revue de reference infirmiere,
I Feghelm
November 2005, Pflege Zeitschrift,
I Feghelm
January 1897, The Journal of comparative medicine and veterinary archives,
I Feghelm
January 2018, Acta crystallographica. Section A, Foundations and advances,
I Feghelm
February 2005, Mental health today (Brighton, England),
I Feghelm
December 2010, Public health,
I Feghelm
June 2005, American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics,
I Feghelm
August 1896, The Journal of comparative medicine and veterinary archives,
Copied contents to your clipboard!